pharmagossip interesting story morning teaser britain chief drug regulator accused big pharma covert distasteful tactics funding patient groups campaign wider use medicines manufacture sir michael rawlins chairman national institute health clinical excellence nice decides drugs provided nhs warned industry sponsorship health charities could lead excessive pressure unfair rulings medicines made available important everybody aware particular patient organisation gets money pharmaceutical industry easy find moment rawlins said patient group may receive money pharmaceutical company may providing help resources use pr manager rawlins added long term patient organisations immense amount damage confidence neutrality dissipate certainly distasteful link full story link reading relationship patient advocacy groups drug companies